Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11753625 Modified NK-92 haNK003 cells for the clinic

Patent 11753625 was granted and assigned to ImmunityBio, Inc. on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Laurent Boissel

Hans Klingemann

Patrick Soon-Shiong

Date of Patent

September 12, 2023

Patent Application Number

16937370

Date Filed

July 23, 2020

Patent Citations

US Patent 10138462 Natural killer cell lines and methods of use

US Patent 7618817 Genetically modified human natural killer cell lines

US Patent 8034332 Interleukin-secreting natural killer cell lines and methods of use

US Patent 8313943 Genetically modified human natural killer cell lines

US Patent 10456420 Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer

Patent Primary Examiner

Provided herein are populations of modified NK-92 cells, compositions and kits comprising the cells, and methods of making and using the populations of cells.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11753625 Modified NK-92 haNK003 cells for the clinic

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool